{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T04:34:25Z","timestamp":1687926865559},"reference-count":29,"publisher":"ALUNA","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>The aim: Determination of vitamin D level and its connection with visual functions in patients with age-related macular degeneration, dry form. \nMaterials and methods: We analyzed the data of studies (25(OH)D3 levels (nmol\/l), LogMAR visual acuity and Logarithmic contrast sensitivity) of 2 groups of women of postmenopausal age: 1 group (58 people \u2013 58 eyes) \u2013 patients with age-related macular degeneration (dry form) \u2013 study group; 2 group (29 people \u2013 29 eyes) \u2013 people without ophthalmic pathology \u2013 control group. \nResults: In the study group, 37 patients (63,8%) had vitamin D deficiency, 21 people (36,2%) had vitamin D insufficiency. In the control group, these figures were 69% and 31%, respectively. These indicators were defined as low (the normal supply of vitamin D is considered to be 100 nmol\/l and more). \nVisual acuity due to ETDRS chart in the study group was 0,22\u00b10,04 (in patients with vitamin D deficiency) and 0,12\u00b10,03 (in patients with vitamin D insuffi\u00acciency), in the control group \u2013 0,13\u00b10,04 and 0,05\u00b10,04 respectively. \nIn the control group, the logarithmic values of contrast sensitivity (log CS) were 1,58\u00b10,04 log CS (in patients with vitamin D deficiency) and 1,62\u00b10,02 log CS (in patients with vitamin D insufficiency). For patients from the study group, these figures were reduced to 0,98\u00b10,1 log CS and 1,10\u00b10,06 log CS respectively. \nConclusions: Patients with age-related macular degeneration, dry form, have low levels of vitamin D, with a predominance of its deficiency. It has been determined that with age-related macular degeneration, functional losses are observed when perceiving objects of low contrast.<\/jats:p>","DOI":"10.36740\/wlek202305206","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T09:20:57Z","timestamp":1687857657000},"page":"1173-1178","source":"Crossref","is-referenced-by-count":0,"title":["VITAMIN D LEVEL AND ITS LINK WITH VISUAL ACUITY AND CONTRAST SENSITIVITY IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION"],"prefix":"10.36740","volume":"76","author":[{"given":"Tetiana M.","family":"Komarova","sequence":"first","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana P.","family":"Vitovska","sequence":"additional","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia I.","family":"Komisarenko","sequence":"additional","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle K.","family":"Scholtz","sequence":"additional","affiliation":[{"name":"UNIVERSIT\u00c4T DES SAARLANDES, HOMBURG, GERMANY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2023]]},"reference":[{"key":"ref0","unstructured":"1. World Health Organization. Prevention of blindness and visual impairment. Priority eye diseases-corneal opacities. http:\/\/www.who. int\/blindness\/causes\/priority\/en\/index9.html. [date access 06.02.2023]."},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Prenner JL, Halperin LS, Rycroft C et al. Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study. American journal of ophthalmology. 2015; 160(4): 725\u2013731. doi:10.1016\/j.ajo.2015.06.023.","DOI":"10.1016\/j.ajo.2015.06.023"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Joachim N, Colijn JM, Kifley A et al. Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report. The British journal of ophthalmology. 2017; 101(9): 1185\u20131192. doi:10.1136\/ bjophthalmol-2016-309729.","DOI":"10.1136\/bjophthalmol-2016-309729"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Wong TY, Chakravarthy U, Klein R et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology. 2008; 115(1): 116\u2013126. doi:10.1016\/j.ophtha.2007.03.008.","DOI":"10.1016\/j.ophtha.2007.03.008"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Wong WL, Su X, Li X et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet. Global health. 2014; 2(2): e106\u2013e116. doi:10.1016\/S2214-109X(13)70145-1.","DOI":"10.1016\/s2214-109x(13)70145-1"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Li JQ, Welchowski T, Schmid M et al. Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis. The British journal of ophthalmology. 2020; 104(8): 1077\u20131084. doi:10.1136\/bjophthalmol-2019-314422.","DOI":"10.1136\/bjophthalmol-2019-314422"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Rein DB, Wittenborn JS, Zhang X et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Archives of ophthalmology (Chicago, Ill.: 1960). 2009; 127(4): 533\u2013540. doi:10.1001\/archophthalmol.2009.58.","DOI":"10.1001\/archophthalmol.2009.58"},{"key":"ref7","unstructured":"8. Skowron K, Pawlicka I, Gil K. The role of vitamin D in the pathogenesis of ocular diseases. Folia medica Cracoviensia. 2018; 58(2): 103\u2013118. doi:10.24425\/fmc.2018.124662."},{"key":"ref8","unstructured":"9. Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discovery medicine. 2011; 11(59). 325\u2013335."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Merle B, Silver RE, Rosner B et al. Associations Between Vitamin D Intake and Progression to Incident Advanced Age-Related Macular Degeneration.Investigative ophthalmology & visual science. 2017; 58(11): 4569\u20134578. doi:10.1167\/iovs.17-21673.","DOI":"10.1167\/iovs.17-21673"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Sowah D, Fan X, Dennett L et al. Vitamin D levels and deficiency with different occupations: a systematic review. BMC public health. 2017; 17(1): 519. doi:10.1186\/s12889-017-4436-z.","DOI":"10.1186\/s12889-017-4436-z"},{"key":"ref11","unstructured":"12. G\u00f3mez Alonso C, Naves D\u00edaz M, Rodr\u00edguez Garc\u00eda M et al. Revisi\u00f3n del concepto de \u201csuficiencia e insuficiencia\u201d de vitamina D [Review of the concept of vitamin D \u201csufficiency and insufficiency\u201d]. Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia. 2003; 23(2): 73\u201377."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Lim SK, Kung AW, Sompongse S et al. Vitamin D inadequacy in postmenopausal women in Eastern Asia. Current medical research and opinion. 2008; 24(1): 99\u2013106. doi:10.1185\/030079908x253429.","DOI":"10.1185\/030079908x253429"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14. Komisarenko YI. Vitamin D deficiency and its role in the development of metabolic disorders in diabetes. Clinical endocrinology and endocrine surgery. 2013; 3 (44): 69-74.","DOI":"10.24026\/1818-1384.3(44).2013.77922"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15. Povoroznyuk VV, Grigorieva NV. Menopause and osteoporosis. Reproductive endocrinology. 2012; 2 (4): 40-47.","DOI":"10.18370\/2309-4117.2012.4.40-47"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16. Wang H, Chen W, Li D et al. Vitamin D and Chronic Diseases. Aging and disease. 2017; 8(3): 346\u2013353. doi:10.14336\/AD.2016.1021.","DOI":"10.14336\/AD.2016.1021"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Aksoy H, Ak\u00e7ay F, Kurtul N et al. Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clinical biochemistry. 2020; 33(1): 47\u201351. doi:10.1016\/s0009-9120(99)00085-5.","DOI":"10.1016\/s0009-9120(99)00085-5"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Luo BA, Gao F, Qin LL. The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis of Observational Studies. Nutrients. 2017; 9(3): 307. doi:10.3390\/nu9030307.","DOI":"10.3390\/nu9030307"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Sabet SJ, Darjatmoko SR, Lindstrom MJ et al. Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors. Archives of ophthalmology (Chicago, Ill.: 1960). 1999; 117(3): 365\u2013370. doi:10.1001\/ archopht.117.3.365.","DOI":"10.1001\/archopht.117.3.365"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Audo I, Darjatmoko SR, Schlamp CL et al. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Investigative ophthalmology & visual science. 2003; 44(10): 4192\u20134199. doi:10.1167\/iovs.02-1198.","DOI":"10.1167\/iovs.02-1198"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Garland CF, Gorham ED, Mohr SB et al. Vitamin D for cancer prevention: global perspective. Annals of epidemiology. 2009; 19(7): 468\u2013483. doi:10.1016\/j.annepidem.2009.03.021.","DOI":"10.1016\/j.annepidem.2009.03.021"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. World Medical Association Declaration of Helsinki. Recommendations guiding doctors in clinical research. Adopted by the World Medical Association in 1964. Wisconsin medical journal. 1967; 66(1): 25\u201326.","DOI":"10.3322\/canjclin.17.3.128"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Bailey IL, Lovie-Kitchin JE. Visual acuity testing. From the laboratory to the clinic. Vision research. 2013; 90: 2\u20139. doi:10.1016\/j. visres.2013.05.004.","DOI":"10.1016\/j.visres.2013.05.004"},{"key":"ref23","unstructured":"24. The Mars Numeral Contrast Sensitivity Test. https:\/\/www.marsperceptrix.com\/sites\/default\/files\/downloads\/ MarsNumeralCSTestUserManualEnglish.pdf. [date access 22.01.2023]."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Chylack LT, Jr Wolfe JK, Singer DM et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Archives of ophthalmology (Chicago, Ill.: 1960). 1993; 111(6): 831\u2013836. doi:10.1001\/archopht.1993.01090060119035.","DOI":"10.1001\/archopht.1993.01090060119035"},{"key":"ref25","unstructured":"26. Age-related macular degeneration NICE guideline. http:\/\/www.nice.org.uk\/guidance\/ng82. [date access 17.02.2023]."},{"key":"ref26","unstructured":"27. Rauscher M. Age-related disorder a stealthy thief of eyesight. https:\/\/jp.reuters.com\/article\/us-age-disorder-s-idUSCOL65269620070206. [date access 19.02.2023]."},{"key":"ref27","unstructured":"28. Cost of Vision Problems \u2013 Medical Costs by Disorder. http:\/\/costofvision.preventblindness.org\/costs\/direct-costs\/medical-costs-by-disorder. [date access 29.01.2023]."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Bivona G, Agnello L, Ciaccio M. The immunological implication of the new vitamin D metabolism. Central-European journal of immunology. 2018; 43(3): 331\u2013334. doi:10.5114\/ceji.2018.80053.","DOI":"10.5114\/ceji.2018.80053"}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T09:21:09Z","timestamp":1687857669000},"score":1,"resource":{"primary":{"URL":"https:\/\/wiadlek.pl\/wp-content\/uploads\/archive\/2023\/05\/WLek202305206.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023]]},"published-print":{"date-parts":[[2023,5]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202305206","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"value":"0043-5147","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}